Search results
Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...
GuruFocus.com via Yahoo Finance· 19 hours agoRevenue: Q1 2024 revenue was $2.2 million, up from $0.7 million in Q1 2023. Cash, Cash Equivalents, and Investments: Ended Q1 2024 with $36.7 million. BARDA Funding: Received ...
University Lab Partners Selected to Lead the Next Generation of the BARDA Accelerator Network as the...
Yucaipa News Mirror· 1 week agoUniversity Lab Partners (ULP), a premier nonprofit wet lab incubator located in Orange County, CA, has been chosen to lead the diagnostics and medical devices hub in the next generation of the ...
BARDA announces first next-generation countermeasure accelerator hubs
Center for Infectious Disease Research and Policy· 1 week agoOne hub focuses on diagnostics and medical devices, and the other targets therapeutics and vaccines.
Q1 2024 Vaxart Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 9 hours agoSecond, we expect to initiate our COVID-19 Phase 2b trial, possibly as early as this quarter, once we are able to secure additional funding and gain regulatory alignment. We have been honored ...
Spectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoSpectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript May 11, 2024 Spectral AI, Inc....
BTIG lowers Spectral AI shares amid slow burn trial enrollment By Investing.com
Investing.com· 7 days agoSpectral AI reported quarterly revenue of $6.3 million, which fell short of BTIG's estimates of $7.0...
EverGlade Consulting Welcomes New Managing Director, Joe Larsen
Tri-County Times· 2 weeks agoEverGlade Consulting is pleased to announce the appointment of Dr. Joe Larsen as Managing Director, effective April 2024. Dr. Larsen brings with him a rich background in biomedical research ...
Magazine: Anticipation rises for RSV rollout as positive data emerges
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoIn this issue: Following the RSV therapy and vaccine rollout, understanding molecular glues, using...
Earnings call: AVITA Medical confronts growth challenges in Q1 By Investing.com
Investing.com· 10 hours agoAVITA Medical, Inc. (RCEL) has reported its first-quarter financial results, revealing a commercial...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
